Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GI-6301 Vaccine with Radiotherapy in Chordoma
NCT02383498Phase 2Completed
- Sponsor
- ImmunityBio, Inc.
- Start
- May 2015
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of gi-6301 in chordoma, sponsored by ImmunityBio, Inc.. Started May 2015; status: completed.
02
Drugs
gi-6301
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT02383498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02383498.